Amicus Therapeutics, Inc. Stock
Stocks
FOLD
US03152W1099
Biotechnology & Medical Research
|
Delayed
Nasdaq
16:00:00 2026-04-24 EDT
|
5-day change | 1st Jan Change | ||
| 14.49 USD | +0.21% |
|
-.--% | +1.76% |
| 05-05 | BioMarin Enters 'Transition Year' as Enzyme Portfolio Expands After Amicus Deal, Morgan Stanley Says | MT |
| 04-28 | Amicus Therapeutics, Inc.(NasdaqGM:FOLD) dropped from S&P Global BMI Index | CI |
| Market Cap | 4.55B 3.99B 3.77B 3.44B 6.43B 436B 6.48B 45.12B 17.48B 223B 17.08B 16.71B 716B | P/E 2024 |
-51.1x | P/E 2025 | -162x |
|---|---|---|---|---|---|
| Enterprise Value | 4.7B 4.12B 3.89B 3.55B 6.64B 450B 6.69B 46.6B 18.05B 230B 17.64B 17.26B 739B | EV / Sales 2024 |
5.69x | EV / Sales 2025 | 7.18x |
| Free-Float |
99.31% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Amicus Therapeutics, Inc.
| 1 day | +0.21% | ||
| 6 months | +0.42% | ||
| Current year | +1.76% |
| Current year | 14.2 |  | 14.5 |
| 1 year | 7.68 | | 14.5 |
| 3 years | 5.51 | | 14.57 |
| 5 years | 5.51 | | 14.57 |
| 10 years | 4.41 | | 25.39 |
| Manager | Title | Age | Since |
|---|---|---|---|
George Davis
PSD | President | 55 | 2026-04-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 4/27/26 | Issuer sale | General Counsel | 1,264,993 | 0.4029% | ||
| 4/27/26 | Issuer sale | Director | 395,940 | 0.1261% | ||
| 4/27/26 | Issuer sale | Chairman | 419,487 | 0.1336% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.21% | -.--% | +75.85% | +18.38% | 4.55B | |
| -0.14% | +4.33% | +9.00% | +31.64% | 47.97B | |
| -1.69% | +1.48% | +50.57% | +34.53% | 44.5B | |
| +2.56% | +7.34% | +366.69% | +608.26% | 43.93B | |
| +0.24% | +2.85% | +10.67% | +94.47% | 41.03B | |
| -0.62% | -1.11% | +4.65% | +48.91% | 29.85B | |
| -0.28% | +1.07% | +24.58% | +155.58% | 17.27B | |
| +3.37% | +9.21% | +8.32% | - | 15.34B | |
| -0.46% | +1.20% | +26.90% | +42.21% | 15.3B | |
| -2.21% | -4.70% | - | - | 14.82B | |
| Average | +0.10% | +2.14% | +64.14% | +129.24% | 27.46B | |
| Weighted average by Cap. | +0.11% | +2.82% | +79.60% | +157.64% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 528M 464M 438M 399M 747M 50.63B 752M 5.24B 2.03B 25.87B 1.98B 1.94B 83.14B | 634M 557M 526M 479M 897M 60.79B 903M 6.29B 2.44B 31.05B 2.38B 2.33B 99.8B |
| Net income | -56.11M -49.23M -46.5M -42.37M -79.32M -5.38B -79.89M -556M -216M -2.75B -211M -206M -8.83B | -27.11M -23.79M -22.47M -20.48M -38.33M -2.6B -38.6M -269M -104M -1.33B -102M -99.59M -4.27B |
| Net Debt | 194M 170M 161M 146M 274M 18.56B 276M 1.92B 744M 9.48B 727M 712M 30.48B | 149M 131M 123M 112M 210M 14.26B 212M 1.48B 572M 7.29B 559M 547M 23.42B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- FOLD Stock
Select your edition
All financial news and data tailored to specific country editions
